解开微生物组-代谢组联系:使用可解释的人工智能进行贝塞特病个性化管理的综合研究协议
Sabina Tangaro1,2, Giuseppe Lopalco3, Daniele Sabella3
1Dipartimento di Scienze del Suolo, della Pianta e degli Alimenti, Università degli Studi di Bari Aldo Moro, Bari, Italy.
Frontiers in microbiology
|February 27, 2024
概括
这项研究探讨了肠道细菌,挥发性化合物和贝赫塞特之间的联系.
科学领域:
- 微生物组研究的研究.
- 挥发力学是一种挥发力学.
- 可解释的人工智能 (XAI)
- 贝塞特病 (BD) 的病原发生.
背景情况:
- 贝塞特病 (BD) 是一种复杂的炎症性疾病,病因因素不明.
- 人类微生物组和挥发组越来越被认为对健康和疾病至关重要.
- 目前BD的诊断和管理策略缺乏准确性和个性化.
研究的目的:
- 调查肠道微生物群,挥发细胞和贝赫塞特病 (BD) 的临床表现之间的复杂关系.
- 利用可解释的人工智能 (XAI) 来分析多模式数据以识别疾病生物标志物和患者子组.
- 评估一种基于可溶性纤维的食补充剂对BD患者的微生物组,挥发性细胞组和临床结果的影响.
主要方法:
- 这是一项三阶段研究,涉及70名BD患者和对照组.
- 数据收集包括口腔/便微生物群,呼吸挥发性有机化合物,临床数据和饮食习惯.
- 分析采用气体染色学-质谱学,转基因测序和先进的XAI算法来实现多模式数据集成.
主要成果:
- 建立微生物群组成,挥发性形状和BD的表型特征之间的相关性.
- 确定与BD和临床结果相关的特定微生物分类学单位和代谢标记.
- 展示XAI能够区分eubiosis和dysbiosis,并预测患者的反应的能力.
结论:
- 该研究方案为了解微生物组在BD病变发生过程中的作用提供了一个框架.
- XAI提供了一种新的数据驱动方法,用于个性化管理和潜在地改善BD患者的治疗结果.
- 这些发现可能为早期诊断和针对贝塞特病的有针对性的治疗干预铺平道路.
更多相关视频
11:22Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
28.0K
09:52A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
Published on: January 10, 2025
590
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
